CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $40,000 | +48.1% | 22,000 | +61.8% | 0.00% | – |
| Q1 2022 | $27,000 | -86.1% | 13,595 | -68.7% | 0.00% | – |
| Q3 2021 | $194,000 | -19.5% | 43,485 | +4.8% | 0.00% | -100.0% |
| Q2 2021 | $241,000 | +153.7% | 41,485 | +108.8% | 0.00% | – |
| Q4 2020 | $95,000 | -56.2% | 19,870 | +523.7% | 0.00% | -100.0% |
| Q4 2017 | $217,000 | -13.5% | 3,186 | +4.7% | 0.00% | -50.0% |
| Q3 2017 | $251,000 | +20.7% | 3,042 | -6.9% | 0.00% | 0.0% |
| Q1 2017 | $208,000 | – | 3,269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |